Danaher's (DHR) Beckman Coulter Diagnostics unit said Monday its clinical chemistry and immunoassay analyzer DxC 500i received 510(k) clearance from the US Food and Drug Administration.
The DxC 500i has a throughput of up to 800 clinical chemistry tests per hour and 100 immunoassay tests per hour, the company said.
Price: 209.03, Change: -3.04, Percent Change: -1.44
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.